CD274 and melanoma: Pretreatment with exosomes from tumors, such as melanoma and breast cancer, significantly inhibited the cytotoxic T cell-mediated tumor killing, which could be counteracted by anti-PD-L1 antibodies (Chen G. et al., 2018; Yang et al., 2018; Kim et al., 2019).